Histogram

Visit number vs Adiponectin - Total
N Mean StdDev Median Min Max Unknown Total
Baseline 49 4.0 ± 2.4 3.3 1.0 13.2 - 49
9-Month Followup 43 4.7 ± 3.0 4.1 1.2 15.6 - 43
18-Month Followup 39 4.9 ± 3.0 4.3 1.2 14.4 1 40
Randomized treatment arm vs Adiponectin - Total
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 4.0 ± 2.4 3.3 1.0 13.2 - 49
Laparoscopic Gastric Banding (LGB) 28 4.6 ± 2.8 4.0 1.0 13.2 - 28
Continuous Positive Airway Pressure (CPAP) 21 3.2 ± 1.6 2.9 1.2 7.0 - 21
Randomized treatment arm vs Adiponectin - Total
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 43 4.7 ± 3.0 4.1 1.2 15.6 - 43
Laparoscopic Gastric Banding (LGB) 25 5.4 ± 3.4 4.6 1.2 15.6 - 25
Continuous Positive Airway Pressure (CPAP) 18 3.7 ± 2.1 3.4 1.6 8.9 - 18
Randomized treatment arm vs Adiponectin - Total
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 4.9 ± 3.0 4.3 1.2 14.4 1 40
Laparoscopic Gastric Banding (LGB) 23 5.7 ± 3.4 5.6 1.2 14.4 1 24
Continuous Positive Airway Pressure (CPAP) 16 3.7 ± 2.0 3.0 1.7 8.0 - 16
Age of the participant vs Adiponectin - Total
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 4.0 ± 2.4 3.3 1.0 13.2 - 49
27.0 to 45.0 years 13 2.6 ± 1.2 2.5 1.2 4.8 - 13
46.0 to 50.0 years 12 3.9 ± 1.7 3.8 1.9 7.5 - 12
51.0 to 56.0 years 12 5.3 ± 3.5 4.0 1.5 13.2 - 12
57.0 to 65.0 years 12 4.3 ± 2.1 4.2 1.0 9.2 - 12
Age of the participant vs Adiponectin - Total
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 43 4.7 ± 3.0 4.1 1.2 15.6 - 43
28.0 to 47.0 years 11 3.0 ± 1.7 2.2 1.6 6.3 - 11
47.0 to 52.0 years 11 4.8 ± 2.4 4.3 1.8 8.9 - 11
52.0 to 58.0 years 11 6.2 ± 4.2 4.5 1.8 15.6 - 11
58.0 to 65.0 years 10 4.8 ± 2.5 4.5 1.2 9.9 - 10
Age of the participant vs Adiponectin - Total
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 4.9 ± 3.0 4.3 1.2 14.4 1 40
29.0 to 46.0 years 10 2.8 ± 1.5 2.2 1.7 6.5 - 10
47.0 to 52.0 years 10 5.1 ± 2.4 4.7 1.9 8.0 - 10
53.0 to 58.0 years 10 6.4 ± 4.3 5.0 1.8 14.4 - 10
58.0 to 65.0 years 9 5.1 ± 2.4 5.6 1.2 8.4 1 10
Gender of the participant vs Adiponectin - Total
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 4.0 ± 2.4 3.3 1.0 13.2 - 49
Male 28 3.1 ± 1.4 3.1 1.0 6.0 - 28
Female 21 5.1 ± 3.0 4.2 1.5 13.2 - 21
Gender of the participant vs Adiponectin - Total
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 43 4.7 ± 3.0 4.1 1.2 15.6 - 43
Male 25 3.8 ± 2.1 3.4 1.2 8.9 - 25
Female 18 5.9 ± 3.7 5.3 1.8 15.6 - 18
Gender of the participant vs Adiponectin - Total
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 4.9 ± 3.0 4.3 1.2 14.4 1 40
Male 24 3.9 ± 2.1 3.8 1.2 7.8 1 25
Female 15 6.4 ± 3.7 5.6 1.8 14.4 - 15
Race of the participant vs Adiponectin - Total
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 46 4.0 ± 2.5 3.5 1.0 13.2 - 46
white 35 4.5 ± 2.5 4.0 1.2 13.2 - 35
american indian or alaska native - - - - - - - -
black or african american 9 2.7 ± 1.7 2.1 1.0 6.7 - 9
asian 2 2.0 ± 0.9 2.0 1.3 2.6 - 2
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -
Race of the participant vs Adiponectin - Total
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 40 4.7 ± 3.1 4.2 1.2 15.6 - 40
white 31 5.2 ± 3.1 4.3 1.6 15.6 - 31
american indian or alaska native - - - - - - - -
black or african american 8 3.4 ± 2.9 2.0 1.2 8.9 - 8
asian 1 2.2 - 2.2 2.2 2.2 - 1
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -
Race of the participant vs Adiponectin - Total
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 36 5.0 ± 3.1 4.4 1.2 14.4 1 37
white 29 5.4 ± 3.1 4.7 1.7 14.4 - 29
american indian or alaska native - - - - - - - -
black or african american 6 3.3 ± 2.5 2.0 1.2 7.3 1 7
asian 1 2.7 - 2.7 2.7 2.7 - 1
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -